{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:56:50Z","timestamp":1779001010775,"version":"3.51.4"},"reference-count":90,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Treatment options for multidrug resistant Acinetobacter baumannii strains (MDR-AB) are limited. Minocycline has been used alone or in combination in the treatment of infections associated with AB. A systematic review of the clinical use of minocycline in nosocomial infections associated with MDR-AB was performed according to the PRISMA-P guidelines. PubMed-Medline, Scopus and Web of Science TM databases were searched from their inception until March 2019. Additional Google Scholar free searches were performed. Out of 2990 articles, 10 clinical studies (9 retrospective case series and 1 prospective single center trial) met the eligibility criteria. In total, 223 out of 268 (83.2%) evaluated patients received a minocycline-based regimen; and 200 out of 218 (91.7%) patients with available data received minocycline as part of a combination antimicrobial regimen (most frequently colistin or carbapenems). Pneumonia was the most common infection type in the 268 cases (80.6% with 50.4% ventilator-associated pneumonia). The clinical and microbiological success rates following minocycline treatment were 72.6% and 60.2%, respectively. Mortality was 20.9% among 167 patients with relevant data. In this systematic review, minocycline demonstrated promising activity against MDR-AB isolates. This review sets the ground for further studies exploring the role of minocycline in the treatment of MDR-AB associated infections.<\/jats:p>","DOI":"10.3390\/microorganisms7060159","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T02:08:40Z","timestamp":1559527720000},"page":"159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-2949","authenticated-orcid":false,"given":"Paraskevi","family":"Fragkou","sequence":"first","affiliation":[{"name":"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens; 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garyfallia","family":"Poulakou","sequence":"additional","affiliation":[{"name":"3rd Department of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andromachi","family":"Blizou","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens; 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrto","family":"Blizou","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens; 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Rapti","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens; 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9959-9978","authenticated-orcid":false,"given":"Drosos","family":"Karageorgopoulos","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens; 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina","family":"Koulenti","sequence":"additional","affiliation":[{"name":"Adult Critical Care Unit, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"},{"name":"BTCCRC, UQCCR, Faculty of Medicine, University of Queensland, Brisbane, QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens; 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Matthaiou","sequence":"additional","affiliation":[{"name":"Adult Critical Care Unit, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0463-4321","authenticated-orcid":false,"given":"Sotirios","family":"Tsiodras","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens; 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"key":"ref_1","first-page":"371","article-title":"Antibacterial Activity in Mice of Minocycline, a New Tetracycline","volume":"6","author":"Redin","year":"1966","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an Antibiotic","volume":"169","author":"Zarzuelo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0025-7125(16)30039-6","article-title":"Tetracyclines","volume":"79","author":"Klein","year":"1995","journal-title":"Med. Clin. North Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and Pharmacodynamics of the Tetracyclines Including Glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of Doxycycline and Minocycline: A Systematic Review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1093\/cid\/ciu613","article-title":"A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections","volume":"59","author":"Ritchie","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed Res. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"Infectious Diseases Society of America. 10 x \u201920 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update from the Infectious Diseases Society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/2049-632X.12125","article-title":"Acinetobacter Baumannii: Evolution of a Global Pathogen","volume":"71","author":"Antunes","year":"2014","journal-title":"Pathog. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/jcm.30.10.2680-2685.1992","article-title":"Ribotyping of the Acinetobacter Calcoaceticus-Acinetobacter Baumannii Complex","volume":"30","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/17460913.3.6.649","article-title":"Drug Treatment for Multidrug-Resistant Acinetobacter Baumannii Infections","volume":"3","author":"Bassetti","year":"2008","journal-title":"Future Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0974-777X.68538","article-title":"Multidrug Resistant Acinetobacter","volume":"2","author":"Manchanda","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/505599","article-title":"Attributable Mortality of Acinetobacter Baumannii Infection among Critically Ill Patients","volume":"43","author":"Falagas","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/517954","article-title":"Clinical and Economic Impact of Multidrug Resistance in Nosocomial Acinetobacter Baumannii Bacteremia","volume":"28","author":"Lee","year":"2007","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10096-007-0371-8","article-title":"Impact of Multi-Drug-Resistant Acinetobacter Baumannii on Clinical Outcomes","volume":"26","author":"Abbo","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/cc4869","article-title":"Attributable Mortality of Acinetobacter Baumannii Infections in Critically Ill Patients: A Systematic Review of Matched Cohort and Case-Control Studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/dkl499","article-title":"Impact of Imipenem Resistance on Mortality in Patients with Acinetobacter Bacteraemia","volume":"59","author":"Kwon","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/cc5911","article-title":"Attributable Mortality of Acinetobacter Baumannii: No Longer a Controversial Issue","volume":"11","author":"Falagas","year":"2007","journal-title":"Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/529198","article-title":"Antimicrobial Resistance: Acinetobacter Baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options","volume":"46","author":"Maragakis","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1086\/504477","article-title":"Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas Aeruginosa","volume":"43","author":"Bonomo","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem Resistance in Acinetobacter Baumannii: Mechanisms and Epidemiology","volume":"12","author":"Poirel","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/jac\/dkr256","article-title":"Molecular Characterization of BlaNDM-1 in an Acinetobacter Baumannii Strain Isolated in Germany in 2007","volume":"66","author":"Pfeifer","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"085","DOI":"10.1055\/s-0034-1398388","article-title":"Acinetobacter Baumannii: Evolution of Antimicrobial Resistance\u2014Treatment Options","volume":"36","author":"Doi","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin Resistance of Acinetobacter Baumannii: Clinical Reports, Mechanisms and Antimicrobial Strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/mdr.2011.0163","article-title":"Activity of Polymyxin B and the Novel Polymyxin Analogue CB-182,804 Against Contemporary Gram-Negative Pathogens in New York City","volume":"18","author":"Quale","year":"2012","journal-title":"Microb. Drug Resist."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 Statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"ref_28","unstructured":"(2019, February 01). Available online: http:\/\/www.prisma-statement.org\/PRISMAStatement\/."},{"key":"ref_29","unstructured":"(2019, February 02). Identifying Healthcare-Associated Infections (HAI) for NHSN Surveillance, Available online:  https:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/2PSC_IdentifyingHAIs_NHSNcurrent.pdf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_31","unstructured":"Vandenbroucke, J.P., von Elm, E., Altman, D.G., G\u00f8tzsche, P.C., Mulrow, C.D., Pocock, S.J., Poole, C., Schlesselman, J.J., and Egger, M. (2007). STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. PLoS Med., 4."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/IPC.0b013e31828bbb82","article-title":"Use of Intravenous Minocycline for the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) and Resistant Gram-Negative Organisms","volume":"22","author":"Bishburg","year":"2014","journal-title":"Infect. Dis. Clin. Pract."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0885066610377975","article-title":"Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia","volume":"25","author":"Chan","year":"2010","journal-title":"J. Intensive Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1093\/cid\/ciu593","article-title":"Bad Bugs Need Old Drugs: A Stewardship Program\u2019s Evaluation of Minocycline for Multidrug-Resistant Acinetobacter Baumannii Infections","volume":"59","author":"Goff","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ipc.0b013e318159d595","article-title":"Minocycline Therapy for Traumatic Wound Infections Caused by the Multidrug-Resistant Acinetobacter Baumannii-Acinetobacter Calcoaceticus Complex","volume":"16","author":"Griffith","year":"2008","journal-title":"Infect. Dis. Clin. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3760\/cma.j.issn.0366-6999.20132047","article-title":"A Combination Regimen of Meropenem, Cefoperazone-Sulbactam and Minocycline for Extensive Burns with Pan-Drug Resistant Acinetobacter Baumannii Infection","volume":"127","author":"Ning","year":"2014","journal-title":"Chin. Med. J. (Engl.)"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1093\/cid\/ciu594","article-title":"Carbapenem-Resistance in Gram-Negative Bacilli and Intravenous Minocycline: An Antimicrobial Stewardship Approach at the Detroit Medical Center","volume":"59","author":"Pogue","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","first-page":"2847","article-title":"[Cefoperazone-Sulbactam plus Minocycline in the Treatment of Extensively Drug Resistant Acinetobacter Infections]","volume":"92","author":"Shi","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_39","first-page":"185","article-title":"[Preliminary Analysis on the Treatment of Ventilator-Associated Pneumonia Caused by Pandrug-Resistant Acinetobacter Baumannii]","volume":"36","author":"Wang","year":"2014","journal-title":"Zhongguo Yi XueKeXue Yuan Xue Bao."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s00134-003-1811-2","article-title":"Tetracyclines for Treating Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia","volume":"29","author":"Wood","year":"2003","journal-title":"Intensive Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3947\/ic.2016.48.4.324","article-title":"Acinetobacter Prosthetic Joint Infection Treated with Debridement and High-Dose Tigecycline","volume":"48","author":"Vila","year":"2016","journal-title":"Infect. Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1099\/jmm.0.000147","article-title":"In Vitro Activity of Minocycline Alone or in Combination in Multidrug-Resistant Acinetobacter Baumannii Isolates","volume":"64","author":"Vay","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1128\/AAC.02994-15","article-title":"In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter Baumannii","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/mdr.2012.0076","article-title":"In Vitro Activity of Minocycline Alone and in Combination with Cefoperazone-Sulbactam Against Carbapenem-Resistant Acinetobacter Baumannii","volume":"18","author":"Pei","year":"2012","journal-title":"Microb. Drug Resist."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liang, W., Liu, X.-F., Huang, J., Zhu, D.-M., Li, J., and Zhang, J. (2011). Activities of Colistin- and Minocycline-Based Combinations against Extensive Drug Resistant Acinetobacter Baumannii Isolates from Intensive Care Unit Patients. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-109"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fmicb.2015.00507","article-title":"In Vitro and in Vivo Analysis of Antimicrobial Agents Alone and in Combination against Multi-Drug Resistant Acinetobacter Baumannii","volume":"6","author":"He","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.04110-14","article-title":"Assessment of Minocycline and Polymyxin B Combination against Acinetobacter Baumannii","volume":"59","author":"Bowers","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1586\/14787210.2013.846215","article-title":"Combination Therapy for Gram-Negative Bacteria: What Is the Evidence?","volume":"11","author":"Kmeid","year":"2013","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/jac\/dku168","article-title":"Combination Therapy for Carbapenem-Resistant Gram-Negative Bacteria","volume":"69","author":"Paul","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10096-014-2124-9","article-title":"Combination Antibiotic Treatment versus Monotherapy for Multidrug-Resistant, Extensively Drug-Resistant, and Pandrug-Resistant Acinetobacter Infections: A Systematic Review","volume":"33","author":"Poulikakos","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-0691.2012.03888.x","article-title":"Asymptomatic Rectal Carriage of BlaKPC Producing Carbapenem-Resistant Enterobacteriaceae: Who Is Prone to Become Clinically Infected?","volume":"19","author":"Schechner","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_52","unstructured":"(2019, March 20). The State of the World\u2019s Antibiotics, 2015\u2014Center for Disease Dynamics, Economics & Policy (CDDEP). Available online: https:\/\/cddep.org\/publications\/state_worlds_antibiotics_2015\/."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Nebulized Antibiotics Study Group. Efficacy of High-Dose Nebulized Colistin in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Pseudomonas Aeruginosa and Acinetobacter Baumannii","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00134-007-0675-2","article-title":"Safety and Efficacy of Colistin Compared with Imipenem in the Treatmentof Ventilator-Associated Pneumonia: AMatched Case\u2013Control Study","volume":"33","author":"Kallel","year":"2007","journal-title":"Intensive Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2009.02.009","article-title":"Tigecycline in the Treatment of Infections from Multi-Drug Resistant Gram-Negative Pathogens","volume":"58","author":"Poulakou","year":"2009","journal-title":"J. Infect."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2015.08.009","article-title":"Efficacy and Safety of Tigecycline for the Treatment of Severe Infectious Diseases: An Updated Meta-Analysis of RCTs","volume":"39","author":"Shen","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1097\/CCM.0000000000001152","article-title":"\u201cExcess Mortality\u201d and Colistin-Tigecycline for Extensively Drug-Resistant Acinetobacter Baumannii Bacteremia","volume":"43","author":"Poulakou","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of Plasmid-Mediated Colistin Resistance Mechanism MCR-1 in Animals and Human Beings in China: A Microbiological and Molecular Biological Study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","article-title":"Efficacy and Safety of Tigecycline for the Treatment of Infectious Diseases: A Meta-Analysis","volume":"11","author":"Tasina","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/jac\/dkr242","article-title":"Efficacy and Safety of Tigecycline: A Systematic Review and Meta-Analysis","volume":"66","author":"Yahav","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.01402-10","article-title":"Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease","volume":"55","author":"Cai","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Curcio, D., and Verde, P.E. (2011). Comment on: Efficacy and Safety of Tigecycline: A Systematic Review and Meta-Analysis Downloaded From. J Antimicrob Chemother J. Antimicrob. Chemother. Adv. Access.","DOI":"10.1093\/jac\/dkr368"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00134-014-3343-3","article-title":"Is There a Future for Tigecycline?","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1017\/ice.2015.143","article-title":"Prevalence of and Risk Factors for Multidrug-Resistant Acinetobacter Baumannii Colonization Among High-Risk Nursing Home Residents","volume":"36","author":"Mody","year":"2015","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhin.2015.10.007","article-title":"Extensively Drug-Resistant Acinetobacter Baumannii in a Lebanese Intensive Care Unit: Risk Factors for Acquisition and Determination of a Colonization Score","volume":"92","author":"Moghnieh","year":"2016","journal-title":"J. Hosp. Infect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/cc11383","article-title":"The Importance of Colonization Pressure in Multiresistant Acinetobacter Baumannii Acquisition in a Greek Intensive Care Unit","volume":"16","author":"Arvaniti","year":"2012","journal-title":"Crit. Care"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1086\/501721","article-title":"\u201cColonization Pressure\u201d and Risk of Acquisition of Methicillin-Resistant Staphylococcus Aureus in a Medical Intensive Care Unit","volume":"21","author":"Merrer","year":"2000","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJMcibr021776","article-title":"Biofilms, Antimicrobial Resistance, and Airway Infection","volume":"347","author":"Prince","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00134-015-4079-4","article-title":"Task Force on Management and Prevention of Acinetobacter Baumannii Infections in the ICU","volume":"41","author":"Dimopoulos","year":"2015","journal-title":"Intensive Care Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID Guidelines for the Management of the Infection Control Measures to Reduce Transmission of Multidrug-Resistant Gram-Negative Bacteria in Hospitalized Patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_71","unstructured":"(2019, March 19). MDRO Management|GuidelinesLibrary|InfectionControl|CDC, Available online: https:\/\/www.cdc.gov\/infectioncontrol\/guidelines\/mdro\/index.html."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3904\/kjim.2015.178","article-title":"Controlling Endemic Multidrug-Resistant Acinetobacter Baumannii in Intensive Care Units Using Antimicrobial Stewardship and Infection Control","volume":"31","author":"Cheon","year":"2016","journal-title":"Korean J. Intern. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8871","DOI":"10.3390\/ijerph120808871","article-title":"Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter Baumannii Infections: Evolution of Old Problems and New Challenges for Institutes","volume":"12","author":"Chen","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/676857","article-title":"Control of Simultaneous Outbreaks of Carbapenemase-Producing Enterobacteriaceae and Extensively Drug-Resistant Acinetobacter Baumannii Infection in an Intensive Care Unit Using Interventions Promoted in the Centers for Disease Control and Prevention 2012 Carbapenemase-Resistant Enterobacteriaceae Toolkit","volume":"35","author":"Enfield","year":"2014","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_75","unstructured":"(2019, May 09). Minocycline intravenous\u2014Melinta Therapeutics\u2013AdisInsight. Available online: https:\/\/adisinsight.springer.com\/drugs\/800041651."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijantimicag.2014.12.031","article-title":"Tetracyclines for Multidrug-Resistant Acinetobacter Baumannii Infections","volume":"45","author":"Falagas","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1183\/09031936.06.00049105","article-title":"Grupo Argentino de Estudio de la Neumon\u00edaAsociada al Respirador group. Appropriateness and Delay to Initiate Therapy in Ventilator-Associated Pneumonia","volume":"27","author":"Luna","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijantimicag.2009.01.015","article-title":"Tigecycline Possibly Underdosed for the Treatment of Pneumonia: A Pharmacokinetic Viewpoint","volume":"34","author":"Burkhardt","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.10-0463","article-title":"Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration","volume":"138","author":"Imberti","year":"2010","journal-title":"Chest"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijantimicag.2016.05.017","article-title":"Comparative Evaluation of Minocycline Susceptibility Testing Methods in Carbapenem-Resistant Acinetobacter Baumannii","volume":"48","author":"Dimitriadis","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1128\/JCM.01810-16","article-title":"Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter Baumannii","volume":"54","author":"Wang","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/dky448","article-title":"Minocycline Susceptibility Breakpoints for Acinetobacter Baumannii: Do We Need to Re-Evaluate Them?","volume":"74","author":"Tsakris","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s40265-016-0636-6","article-title":"Intravenous Minocycline: A Review in Acinetobacter Infections","volume":"76","author":"Greig","year":"2016","journal-title":"Drugs"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/IPC.0b013e318245d50a","article-title":"A Stewardship Approach to Combating Multidrug-Resistant Acinetobacter Baumannii Infections With Minocycline","volume":"20","author":"Jankowski","year":"2012","journal-title":"Infect. Dis. Clin. Pract."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkn165","article-title":"Tigecycline for the Treatment of Multidrug-Resistant (Including Carbapenem-Resistant) Acinetobacter Infections: A Review of the Scientific Evidence","volume":"62","author":"Karageorgopoulos","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijantimicag.2015.11.011","article-title":"Tigecycline Treatment Experience against Multidrug-Resistant Acinetobacter Baumannii Infections: A Systematic Review and Meta-Analysis","volume":"47","author":"Ni","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5114\/aoms.2015.48158","article-title":"Clinical Efficacy and Safety of Colistin Treatment in Patients with Pulmonary Infection Caused by Pseudomonas Aeruginosa or Acinetobacter Baumannii: A Meta-Analysis","volume":"11","author":"Zhang","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bjid.2012.10.029","article-title":"Sulbactam-Based Therapy for Acinetobacter Baumannii Infection: A Systematic Review and Meta-Analysis","volume":"17","author":"Chu","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_90","unstructured":"Ozger, H.S., Cuhadar, T., Yildiz, S.S., DemirbasGulmez, Z., Dizbay, M., GuzelTunccan, O., Kalkanci, A., Simsek, H., and Unaldi, O. (2019). In Vitro Activity of Eravacycline in Combination with Colistin against Carbapenem-Resistant A. Baumannii Isolates. J. Antibiot. (Tokyo), 1."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/7\/6\/159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:55:25Z","timestamp":1760187325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/7\/6\/159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":90,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["microorganisms7060159"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms7060159","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}